
Alvotech Ordinary Shares
ALVO
ALVO: Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
moreShow ALVO Financials
Recent trades of ALVO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ALVO's directors and management
Government lobbying spending instances
-
$30,000 Jan 19, 2022 Issue: Copyright/Patent/Trademark Health Issues
-
$50,000 Oct 18, 2021 Issue: Copyright/Patent/Trademark Health Issues
-
$40,000 Jul 20, 2021 Issue: Health Issues Copyright/Patent/Trademark
New patents grants
Federal grants, loans, and purchases
Followers on ALVO's company Twitter account
Number of mentions of ALVO in WallStreetBets Daily Discussion
Recent insights relating to ALVO
Recent picks made for ALVO stock on CNBC
ETFs with the largest estimated holdings in ALVO
Flights by private jets registered to ALVO